IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro

12Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Non-small-cell lung cancer (NSCLC) accounts for more than half of all lung cancer cases. Cytokines play an important role in NSCLC, including IL-27. IL-27 inhibits NSCLC progression; however, the mechanism is not clear. The purpose of this study is to investigate the effects of IL-27 on NSCLC cell proliferation and metastasis. Materials and methods: NSCLC cells were treated with IL-27 or transfected with miR-935, and the cell proliferation was assayed by Cell Counting Kit-8 (CCK-8) and colony formation. Cell metastasis was analyzed by Transwell chamber system and wound healing assay. IL-27 protein in the medium was analyzed by ELISA. IL-27 mRNA expression was measured by quantitative reverse transcriptase-PCR. Results: We found that IL-27 played an inhibiting role in NSCLC cell proliferation and metastasis. The molecular mechanism of the suppressing role of IL-27 in NSCLC was regulated by miR-935. IL-27 expression was negatively associated with miR-935 in the clinical NSCLC samples. Conclusion: The study revealed that IL-27 decreased lung cancer cell proliferation and metastasis via miR-935.

Cite

CITATION STYLE

APA

Wang, T., Chen, Y., Nie, H., Huang, Y., Zhao, Y., & Yang, J. (2019). IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro. OncoTargets and Therapy, 12, 1447–1454. https://doi.org/10.2147/OTT.S173207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free